Cargando…
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt
BACKGROUND: Targeting protein kinase B (Akt) and its downstream signaling proteins are promising options in designing novel and potent drug candidates against hepatocellular carcinoma (HCC). The present study explores the anti-HCC potentials of Cannabis sativa (C. sativa) extract via the involvement...
Autores principales: | Akinloye, Dorcas I., Metibemu, Damilohun S., Shittu, Mujidat T., Lawal, Mariam A., Olatunji, Faith O., Oyediran, Muideen A., Akinloye, Oluseyi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337064/ https://www.ncbi.nlm.nih.gov/pubmed/37434213 http://dx.doi.org/10.1186/s42238-023-00190-z |
Ejemplares similares
-
Carotenoid-Enriched Fractions From Spondias mombin Demonstrate HER2 ATP Kinase Domain Inhibition: Computational and In Vivo Animal Model of Breast Carcinoma Studies
por: Metibemu, Damilohun Samuel, et al.
Publicado: (2021) -
VEGFR-2 kinase domain inhibition as a scaffold for anti-angiogenesis: Validation of the anti-angiogenic effects of carotenoids from Spondias mombin in DMBA model of breast carcinoma in Wistar rats
por: Metibemu, Damilohun Samuel, et al.
Publicado: (2021) -
Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR
por: David, Temitope.I, et al.
Publicado: (2018) -
Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
por: Ore, Ayokanmi, et al.
Publicado: (2019) -
Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
por: Ore, Ayokanmi, et al.
Publicado: (2021)